France has reported the first documented human infection with the Shamonda virus, a disease previously known to affect animals, particularly cattle. The patient, who was being treated for a serious illness and had a severely weakened immune system, died in early October 2026. French authorities announced the case on October 22. Investigations are continuing to understand how the infection occurred and whether the virus contributed to the patient’s death.
The report has attracted international attention because the Shamonda virus was not previously known to infect humans. However, French authorities say that no public health risk to the general population has been identified at this stage. Health experts are monitoring the situation while further investigations take place.
What Is the Shamonda Virus?
Shamonda virus is an orthobunyavirus that has primarily been detected in animals. It was first identified in Nigeria in the mid-1960s and has since been reported sporadically in livestock in parts of Africa and Japan.
The virus is associated mainly with cattle, although infections have also been detected in other animals, including sheep, goats, horses and alpacas. Until the recent French case, no human infection had been documented.
Shamonda virus is transmitted to animals through the bites of tiny insects known as Culicoides biting midges. These insects can carry certain viruses between susceptible animals. Researchers are now investigating whether a similar route of transmission was responsible for the human infection in France.
Details of the First Human Case in France
According to French authorities, the patient was receiving treatment at Hospices Civils de Lyon for a serious underlying illness. The individual was severely immunocompromised, meaning the immune system was not functioning normally and the body was less able to fight infections.
The patient died in early October, but the infection was publicly reported on October 22. French authorities said that complications affecting the brain before the patient’s death were very likely linked to the Shamonda virus infection, based on investigations carried out so far.
However, the European Centre for Disease Prevention and Control (ECDC) has stated that investigations are still underway to determine whether the virus caused or contributed to the death. The exact circumstances of the infection also remain under investigation.
The patient’s weakened immune system is an important factor in this case. Scientists need more evidence to understand whether Shamonda virus can cause similar illness in people with healthy immune systems.
How Did the Patient Become Infected?
The leading hypothesis is that the patient was bitten by an infected Culicoides midge in eastern France. The region had reported circulation of the virus among animals during the spring and summer of 2026.
This possible route of infection is consistent with how the virus spreads among animals. However, investigators have not yet established every detail of how the patient acquired the infection.
Clinical, laboratory and epidemiological investigations are continuing. These efforts involve specialists working across human health, animal health and environmental science, following a One Health approach.
The investigation may help researchers understand whether this was an isolated event or whether other infections could have gone undetected. French authorities have also informed international health organisations about the case.
Is Shamonda Virus Dangerous to Humans?
The discovery of a human infection is significant because the virus was previously considered not to infect humans. Nevertheless, one documented case does not automatically mean that the virus is spreading widely among people.
French authorities have said that, based on current knowledge, no health risk to the general population has been identified. The ECDC is monitoring the situation and working with French authorities and European partners to assess its possible public health implications.
At present, there is no established evidence from this case of sustained human-to-human transmission. The available information also does not establish how often human infections might occur or how the virus would affect people with different levels of immune protection.
Researchers will need more information before drawing wider conclusions about the virus’s ability to infect humans. For now, the case is being treated as an exceptional event involving a severely immunocompromised patient.
What Symptoms Does Shamonda Virus Cause?
Information about Shamonda virus in humans remains very limited because this is the first documented human infection. Scientists therefore cannot yet provide a reliable list of typical human symptoms or describe the full range of illness it might cause.
In animals, particularly cattle, reported signs associated with infection can include fever, reduced appetite, tiredness and diarrhoea. Dairy cattle may also experience a decline in milk production. These animal symptoms should not be assumed to predict how the virus would affect humans.
In the French case, authorities reported neurological complications before the patient’s death and said these were very likely linked to the infection. Further research is needed to understand the relationship between the virus, the patient’s underlying illness and the reported complications.
Anyone concerned about a possible infection should seek advice from a qualified healthcare professional rather than attempting to diagnose the illness based on symptoms alone.
Shamonda Virus Has Spread Among Livestock in Europe
The human case follows the detection of Shamonda virus in European farm animals during 2026. The virus was identified in livestock in Europe for the first time that summer, after earlier circulation had been reported in other parts of the world.
According to the ECDC, animal infections have been detected in several European countries, including Austria, Belgium, France, Germany, Ireland, Italy, Liechtenstein, Luxembourg, the Netherlands, Portugal, Spain and Switzerland, as well as Jersey.
Cattle are considered the main animal hosts, although infections have also been reported in other livestock and equids. The spread among animals has increased the importance of surveillance and research into the insects that transmit the virus.
The human case highlights why animal health monitoring can also be important for public health. Detecting a virus in livestock and understanding how it circulates can help researchers identify unusual developments and investigate potential risks to people.
What Are Health Authorities Doing Now?
French authorities are continuing laboratory, clinical and epidemiological investigations to establish how the infection occurred and what role the virus played in the patient’s illness.
The ECDC is coordinating with French authorities and European partners to assess the implications of the case. It is also working with the relevant European reference laboratory to strengthen testing capacity and help countries identify any additional potential cases.
These steps are intended to improve understanding of the virus rather than indicate that a widespread human outbreak has occurred. Further evidence will be needed to assess whether this infection represents an isolated event or a broader change in the virus’s behaviour.
Should the Public Be Worried About Shamonda Virus?
Based on the information available as of October 23, 2026, authorities have not identified a health risk to the general population. The case remains important because it is the first documented detection of Shamonda virus in a human, but the available evidence does not indicate a widespread outbreak among people.
The most important questions are how the patient became infected, whether the virus contributed to the death, and whether any additional human infections have occurred. Ongoing surveillance and laboratory testing should help answer these questions.
People should follow updates from recognised public health authorities and avoid sharing unverified claims about a new outbreak. The situation may become clearer as more investigation results are released.
Conclusion
France’s first documented human case of Shamonda virus marks an important development in the monitoring of animal-borne infections. The patient had a serious underlying illness and a severely weakened immune system, and investigators are still examining how the infection occurred and whether it contributed to the death.
Although the discovery requires careful investigation, French authorities have not identified a public health risk to the general population. Continued research, animal surveillance and cooperation between health organisations will be important for understanding this unusual case.
